• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Myriad Genetics Inc. (MYGN)

    -NasdaqGS
    34.07 Down 0.89(2.55%) Feb 27, 4:00PM EST
    |After Hours : 34.06 Down 0.01 (0.03%) Feb 27, 4:57PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2014Jun 30, 2013Jun 30, 2012
    Total Revenue 778,216   613,165   496,005  
    Cost of Revenue109,201  79,618  64,659  
    Gross Profit 669,015   533,547   431,346  
    Operating Expenses
    Research Development67,476  53,706  42,645  
    Selling General and Administrative327,097  251,839  208,383  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 274,442   228,002   180,318  
    Income from Continuing Operations
    Total Other Income/Expenses Net3,423  5,274  4,222  
    Earnings Before Interest And Taxes277,865  233,276  184,540  
    Interest Expense -   -   -  
    Income Before Tax277,865  233,276  184,540  
    Income Tax Expense101,640  86,137  72,389  
    Minority Interest -   -   -  
    Net Income From Continuing Ops176,225  147,139  112,151  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 176,225   147,139   112,151  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 176,225   147,139   112,151  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.